X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3583) 3583
Book / eBook (560) 560
Publication (350) 350
Book Review (62) 62
Book Chapter (35) 35
Newspaper Article (15) 15
Dissertation (8) 8
Conference Proceeding (5) 5
Newsletter (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2530) 2530
index medicus (1930) 1930
male (1271) 1271
animals (1180) 1180
female (1023) 1023
cancer (1008) 1008
tumors (965) 965
oncology (923) 923
mice (662) 662
middle aged (569) 569
tumor lysis syndrome - etiology (531) 531
inflammation (500) 500
adult (488) 488
medicine (456) 456
apoptosis (427) 427
expression (406) 406
aged (405) 405
proteins (400) 400
immunology (397) 397
neoplasms (395) 395
research (394) 394
tumor-necrosis-factor (387) 387
cell line, tumor (370) 370
cytokines (368) 368
cell biology (366) 366
gene expression (356) 356
risk factors (355) 355
hematology (350) 350
tumor lysis syndrome (331) 331
analysis (324) 324
health aspects (322) 322
research article (322) 322
multidisciplinary sciences (305) 305
rodents (304) 304
care and treatment (296) 296
chemotherapy (288) 288
child (288) 288
medicine & public health (279) 279
biochemistry & molecular biology (268) 268
disease models, animal (259) 259
genetic aspects (259) 259
pathology (255) 255
diagnosis (252) 252
article (242) 242
science (240) 240
therapy (236) 236
signal transduction (233) 233
rats (231) 231
mutation (225) 225
tumor necrosis factor-tnf (222) 222
disease (221) 221
surgery (221) 221
activation (216) 216
mice, inbred c57bl (215) 215
physiological aspects (213) 213
adolescent (201) 201
kinases (199) 199
cells (196) 196
development and progression (195) 195
leukemia (195) 195
antineoplastic agents - adverse effects (193) 193
oxidative stress (191) 191
pathogenesis (188) 188
neurosciences (184) 184
treatment outcome (181) 181
metastasis (180) 180
biology (178) 178
pediatrics (178) 178
diseases (177) 177
medicine, research & experimental (177) 177
pharmacology & pharmacy (175) 175
child, preschool (172) 172
cells, cultured (171) 171
tumor necrosis factor-alpha - metabolism (170) 170
patients (168) 168
tumor necrosis factor (164) 164
studies (163) 163
prognosis (160) 160
medical research (158) 158
genes (157) 157
immunohistochemistry (157) 157
children (155) 155
immunotherapy (150) 150
infant (149) 149
genetics (148) 148
physiology (148) 148
lymphoma (147) 147
liver (145) 145
tumor necrosis factor-α (145) 145
metabolism (141) 141
tumor (138) 138
carcinoma (137) 137
tnf-alpha (134) 134
nf-kappa-b (133) 133
cell proliferation (132) 132
internal medicine (132) 132
gene-expression (131) 131
aged, 80 and over (130) 130
tumor lysis syndrome - therapy (130) 130
antineoplastic combined chemotherapy protocols - adverse effects (129) 129
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (415) 415
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (36) 36
Collection Dvlpm't (Acquisitions) - Closed Orders (33) 33
Collection Dvlpm't (Acquisitions) - Vendor file (20) 20
UTL at Downsview - May be requested (11) 11
St. Michael's Hospital - Stacks (8) 8
Scarborough Hospital - General (7) 7
Credit Valley Hospital - Stacks (5) 5
Gerstein Science - Circulation Desk (5) 5
Online Resources - Online (5) 5
Scarborough Hospital - Birchmount (5) 5
UofT at Mississauga - Stacks (5) 5
Humber River Regional Hospital - Finch Stacks (4) 4
Lakeridge Health Sciences - Oshawa (4) 4
Markham Stouffville Hospital - Stacks (4) 4
Humber River Regional Hospital - Church Stacks (3) 3
Dentistry (Harry R Abbott) - Stacks (2) 2
Gerstein Science - Not Returned (2) 2
Providence Healthcare - Stacks (2) 2
St Josephs Health Centre - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Credit Valley Hospital - Special Collections (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Reference (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Stacks (1) 1
Markham Stouffville Hospital - Storage (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Stacks (1) 1
Physics - Stacks (1) 1
Providence Healthcare - Withdrawn (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
Toronto East General Hospital - Missing (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4109) 4109
Japanese (40) 40
Spanish (33) 33
German (18) 18
French (16) 16
Chinese (8) 8
Italian (4) 4
Russian (4) 4
Dutch (3) 3
Portuguese (3) 3
Arabic (2) 2
Polish (2) 2
Czech (1) 1
Danish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Norwegian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 10/2004, Volume 127, Issue 1, pp. 3 - 11
Journal Article
Cancer Discovery, ISSN 2159-8274, 06/2016, Volume 6, Issue 6, pp. 664 - 679
Journal Article
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2016, Volume 374, Issue 4, pp. 311 - 322
An oral inhibitor of BCL2 produces substantial responses in the majority of patients with refractory chronic lymphocytic leukemia. The agent is so effective... 
DOSE-ESCALATION | APOPTOSIS | MEDICINE, GENERAL & INTERNAL | CLL | INTERNATIONAL WORKSHOP | CYCLOPHOSPHAMIDE | RITUXIMAB | IBRUTINIB | INHIBITOR | PHASE-I | FLUDARABINE | Recurrence | Humans | Middle Aged | Male | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Antineoplastic Agents - administration & dosage | Remission Induction | Sulfonamides - pharmacokinetics | Dose-Response Relationship, Drug | Disease-Free Survival | Bridged Bicyclo Compounds, Heterocyclic - adverse effects | Tumor Lysis Syndrome - etiology | Antineoplastic Agents - adverse effects | Aged, 80 and over | Sulfonamides - adverse effects | Adult | Female | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Aged | Antineoplastic Agents - pharmacokinetics | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Sulfonamides - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - pharmacokinetics | Antimitotic agents | Treatment outcome | Care and treatment | Usage | Safety and security measures | Lymphocytic leukemia | Analysis | Clinical trials | Dosage and administration | Antineoplastic agents | Pharmacokinetics | Risk factors | Flow cytometry | Chronic lymphatic leukemia | Cell survival | Leukemia | Minimal residual disease | Diarrhea | Chromosome deletion | Nausea | Lymphatic leukemia | Lymphoma | Patients | Proteins | Chemotherapy | Fludarabine | Clonal deletion | Lysis | Respiratory tract diseases | Lymphomas | Chromosome 17 | Neutropenia | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2013, Volume 162, Issue 4, pp. 489 - 497
Summary In tumour lysis syndrome (TLS), metabolic alterations caused by the destruction of malignant cells manifest as laboratory abnormalities with (clinical... 
haemodialysis | acute kidney failure | haematologic malignancy | hyperphosphataemia | intensive care units | Intensive care units | Hyperphosphataemia | Acute kidney failure | Haemodialysis | Haematologic malignancy | BURKITT LYMPHOMA/LEUKEMIA | PREVENTION | ACUTE-RENAL-FAILURE | RECOMBINANT URATE OXIDASE | PREDICTIVE MODEL | ACUTE MYELOID-LEUKEMIA | CHEMOTHERAPY | CANCER-PATIENTS | HYPERURICEMIA | HEMATOLOGY | CRITICALLY-ILL PATIENTS | Fluid Therapy | Urate Oxidase - therapeutic use | Prevalence | Prospective Studies | Hematologic Neoplasms - mortality | Humans | Middle Aged | Tumor Lysis Syndrome - blood | Male | Renal Replacement Therapy - utilization | Tumor Lysis Syndrome - etiology | Tumor Lysis Syndrome - epidemiology | Adult | Female | Acute Kidney Injury - chemically induced | Hematologic Neoplasms - complications | Drug Therapy, Combination | Urate Oxidase - administration & dosage | Acute Kidney Injury - drug therapy | Comorbidity | Acute Kidney Injury - blood | Risk Factors | Proportional Hazards Models | Tumor Burden | Remission Induction | Disease-Free Survival | Allopurinol - therapeutic use | Bicarbonates - administration & dosage | Allopurinol - administration & dosage | Hyperphosphatemia - etiology | Biomarkers | Hematologic Neoplasms - drug therapy | Hyperphosphatemia - drug therapy | Acute Kidney Injury - therapy | Aged | Tumor Lysis Syndrome - drug therapy | Acute Kidney Injury - epidemiology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2011, Volume 365, Issue 8, pp. 725 - 733
Journal Article